Search Results - "Lapras, Véronique"
-
1
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
Published in Endocrine Connections (01-03-2020)“…Objective Somatostatin receptor type 5 (SST5) is inconsistently expressed by corticotroph tumors, with higher expression found in corticotropinomas having…”
Get full text
Journal Article -
2
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences
Published in Endocrine-related cancer (01-04-2015)“…Responses of GH-secreting adenomas to multimodal management of acromegaly vary widely between patients. Understanding the behavioral patterns of GH-secreting…”
Get full text
Journal Article Web Resource -
3
Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification
Published in Pituitary (01-10-2019)“…Purpose Cavernous sinus invasion by pituitary adenomas is an important prognostic factor for evaluating the possibilities of complete remission and to guide…”
Get full text
Journal Article -
4
Postoperative remission of non-invasive lactotroph pituitary tumor: A single-center experience
Published in Annales d'endocrinologie (01-02-2022)“…Dopaminergic agonists (DA) are the first-line treatment in lactotroph pituitary tumor but treatment usually needs to be life-long. After surgical transsphenoid…”
Get full text
Journal Article -
5
Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer
Published in Thyroid (New York, N.Y.) (01-09-2018)“…Dysregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is frequent in advanced follicular (FTC) and poorly differentiated thyroid (PDTC) carcinomas…”
Get more information
Journal Article -
6
Tumor-free osteosclerotic lesions in patients treated for metastatic melanoma using BRAF inhibitors
Published in Melanoma research (01-02-2017)“…BRAF inhibitors (vemurafenib and dabrafenib) are commonly prescribed in BRAF-mutant metastatic melanoma and allow improvement of the overall survival and…”
Get full text
Journal Article -
7
Predicting thyroid nodule malignancy at several prevalence values with a combined Bethesda-molecular test
Published in Translational research : the journal of laboratory and clinical medicine (01-10-2017)“…Investigation of thyroid nodules using fine-needle aspiration cytology (FNAC) gives indeterminate results in up to 30% of samples using the Bethesda System for…”
Get full text
Journal Article -
8
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?
Published in Acta oncologica (02-08-2016)Get more information
Journal Article -
9
Reconsidering olfactory bulb magnetic resonance patterns in Kallmann syndrome
Published in Annales d'endocrinologie (01-10-2017)“…The aim of this retrospective study was to perform magnetic resonance imaging assessment of olfactory pathway and skull base abnormalities in Kallmann syndrome…”
Get full text
Journal Article -
10
Thyroglobulin measurement in fine-needle aspirates of lymph nodes in patients with differentiated thyroid cancer: a simple definition of the threshold value, with emphasis on potential pitfalls of the method
Published in Clinical chemistry and laboratory medicine (01-08-2010)“…Thyroglobulin measurements in fine-needle aspirate (FNA-Tg) is an accurate method for the diagnosis of lymph node metastasis in differentiated thyroid…”
Get more information
Journal Article -
11
Lofgren syndrome and peritoneal involvement by sarcoidosis: case report
Published in Chest (01-07-2007)“…An unusual case of a patient with Löfgren syndrome peritoneal involvement by sarcoidosis. A 36-year-old woman presented with Löfgren syndrome and an increase…”
Get more information
Journal Article -
12
Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
Published in Cytopathology (Oxford) (01-01-2021)“…Introduction The cytological diagnosis of follicular‐patterned thyroid lesions is challenging, especially since the World Health Organisation classification…”
Get full text
Journal Article -
13
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal
Published in Neurosurgical focus (01-04-2011)“…Because of their size and lateral extension, total removal of nonfunctioning pituitary adenomas (NFPAs) remains a challenge and postoperative tumor remnants…”
Get full text
Journal Article -
14
Is Gross Total Resection Reasonable in Adults with Craniopharyngiomas with Hypothalamic Involvement?
Published in World neurosurgery (01-09-2019)“…The treatment of hypothalamus-invading craniopharyngiomas, based on pediatric experience, is subtotal resection (STR) with radiotherapy. This strategy…”
Get full text
Journal Article -
15
Mutation profiling of thyroid liquid-based fine needle aspirations improves diagnostic accuracy
Published in Pathology (2014)“…Fine needle aspiration (FNA) is widely recognized as a reliable diagnostic method to evaluate thyroid nodules. Recently use of molecular biomarkers was…”
Get full text
Journal Article -
16
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal: Personal experience and review of the literature
Published in Neurosurgical focus (01-04-2011)“…Object Because of their size and lateral extension, total removal of nonfunctioning pituitary adenomas (NFPAs) remains a challenge and postoperative tumor…”
Get full text
Journal Article -
17
Feasibility and performance of the Idylla™ NRAS/BRAF cartridge mutation assay on thyroid liquid‐based fine‐needle aspiration
Published in Diagnostic cytopathology (01-12-2021)“…Background Thyroid nodules with indeterminate cytology represent up to 30% of cases. Molecular testing is now highly recommended to improve management. This…”
Get full text
Journal Article -
18
OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
Published in Journal of the Endocrine Society (08-05-2020)“…Abstract Context. Somatostatin receptor type 5 (SST5), a target of pasireotide, is inconsistently expressed by corticotroph tumors. Somatic driver mutations in…”
Get full text
Journal Article -
19
How T2-weighted signal intensity of GH-secreting adenomas correlates with response to primary somatostatin analogue therapy in acromegaly
Published in Acta clinica belgica (English ed. Online) (01-03-2016)“…In order to ensure the best management of acromegalic patients with the varied therapeutic possibilities now available, identifying predictive factors of…”
Get full text
Journal Article